Le Lézard
Classified in: Science and technology
Subjects: SLS, SBS

How AI Writing Assistant Linguix Can Save 25% of Sales Prospects


MIAMI, April 18, 2022 /PRNewswire/ -- On average, sales professionals send 36.2 emails per day and spend 31% of their working time writing them.

No wonder that, due to such time limitations, many employees would just send emails "as is," without any revision or re-reading.

However, according to a new data analysis from an AI writing assistant Linguix, your sales reps better pay attention to grammar and spelling.

To better understand how this affects sales, Linguix's team analyzed data from 50,000 respondents.

Key takeaways

Read the full report: https://linguix.com/blog/how-grammar-mistakes-affect-email-communication-a-new-survey/ 

It's widely believed that non-natives who speak English fluently are better accepted and earn more. Linguix is committed to helping sound more native, at least, when it comes to the written language, by offering AI-based solutions that empower employees to make the most of their written communications.

"Unlike other AI writing assistants, Linguix focuses on maximizing productivity and efficiency of professional communication. This is why, not only does our product help to fix grammar mistakes, but actually improves content using intelligent AI-based rewriting algorithms. Thus, professionals can always be sure their emails are compelling, efficient, and error-free by default," explained founder and CEO Alex Lashkov.

Alex added: "Companies should pay more attention to providing employees with all the necessary tools to help them improve their writing. We created Linguix with the goal of helping people to communicate clearly and effectively."

About Linguix

Linguix is an AI-powered software that helps more than 170,000 users, by offering intelligent tools which are designed to help you write powerfully, clearly and correctly?whether you are writing business emails, essays, text messages or crafting a CV.

https://linguix.com 

Contact:
Mary Glazkova,
+1(305)798-97-55
[email protected]

SOURCE Linguix


These press releases may also interest you

at 20:14
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 20:00
SUNRATE, an intelligent global payment and treasury management platform today announced it has joined Mastercard Priceless Planet Coalition in support of fighting climate change through funding the restoration of 100 million trees. This announcement...

at 20:00
The advanced laser and plasma solution provider from Taiwan, E&R Engineering Corp., is confirmed to attend the feast in Semiconductor industry, Semicon SEA 2024, held in Kuala Lumpur, Malaysia. With the 30-year dedication in the semiconductor...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...



News published on and distributed by: